We've heard all about the 15 sites being up and running for the Tiger...Let's get the US Trials.gov site updated as well. I've notivced their SEDI filings are totally out of date as well, the former head of Dialco stepped down in July and still shows as an insider. I've noticed the "invester presentation" is listed as "COMING SOON" on their webbed site, sounds like a movie poster....
The recent activity looks as though they "moved it" out of harm's way with next to NO true breadth of participation. Simply allowing house #7 T.D. to fill their pockets and take on the
retail appearance.
We need this AGP group to step up and say something sooner rather than later. A near 5 month chart draw clearly states that NOBODY, including our treasured insiders received ANY kind of a deal at 42.5 cents CAD....indeed ; - ) ...
Here is the outdated US Trials.gov site:
Trial record 3 of 11 for: toraymyxin
Safety and Efficacy of Polymyxin B Hemoperfusion (PMX) for Endotoxemic Septic Shock in a Randomized, Open-Label Study (TIGRIS)
 | The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03901807 |
Recruitment Status : Recruiting First Posted : April 3, 2019 Last Update Posted : September 14, 2021 |